 |
Axial Biotherapeutics
Last updated: June 14, 2024
David Donabedian - Cofounder, CEO
USA | Funding: $115.9M (+)
Website: https://www.axialbiotherapeutics.com/
Axial Biotherapeutics is a biopharmaceutical company harnessing the link between the human gut microbiome and Central Nervous System to develop a new class of therapeutics to improve the quality of life for people with CNS diseases and disorders
Website: https://www.axialbiotherapeutics.com/
Axial Biotherapeutics is a biopharmaceutical company harnessing the link between the human gut microbiome and Central Nervous System to develop a new class of therapeutics to improve the quality of life for people with CNS diseases and disorders
